Journal of Neurology

Article	Citations
The deltoid muscle and the pattern of paresis in ALS	229
Neuromyelitis optica spectrum disorder with a familial Mediterranean fever gene E84K mutation	210
Tacrolimus-induced Parkinsonism	154
Halting progressive multifocal leukoencephalopathy with pembrolizumab: the case of a patient with multiple sclerosis under fingolimod	106
The DeMyers: Marian (1922–2012) and William (1924–2008)	101
Risk of secondary progression in patients with highly active multiple sclerosis treated with natalizumab: a real-life study	99
Tourette syndrome: effects of acetyl-leucine in two individuals	94
Phenotype-driven reanalysis reveals five novel pathogenic variants in 40 exome-negative families with Charcot–Marie–Tooth Disease	89
Dizziness and spatial disorientation in patients with transient global amnesia: clinical and vestibular correlates	87
Stroke frequency, associated factors, and clinical features in primary systemic vasculitis: a multicentric observational study	81
Hashimoto’s encephalopathy with diffuse leukoencephalopathy: serial MRI and gait analysis	81
Nomograms integrating cortical morphometric metrics with 3D multi-parametric MRI radiomics for predicting disability progression and cognitive worsening in relapsing–remitting multiple sclerosis: a mu	79
Performance of blind source separation in localizing seizure onset from routine scalp-EEG	79
Assessment of cognitive function, structural brain changes and fatigue 6 months after treatment of neuroborreliosis	79
Correction to: Synergistic effects of vagus nerve stimulation and antiseizure medication	77
Effects of deep brain stimulation on non-motor symptoms in Parkinson’s disease: insights from longitudinal studies using consistent evaluation scales	72
Different patterns of acute saccadic response to levodopa in de novo Parkinson’s disease	72
Humoral response after accelerated schedule of HBV vaccination in MS patients before anti-CD20 therapy	72
Incidence of Guillain–Barré syndrome in Cuba before and during the Oropouche virus emergency, 2018–2024	69
Neurological manifestation of HEV infection: still a rare disease entity?	65
Long-term safety and efficacy of ponesimod in participants with relapsing multiple sclerosis: results from the phase 3 OPTIMUM 5-year long term extension study	65
Cross-sectional brain volumetric measures and disability outcomes in relapsing–remitting multiple sclerosis	62
Dystonia management across Europe within ERN-RND: current state and future challenges	61
Interpretable deep learning survival predictions in sporadic Creutzfeldt–Jakob disease	60
Improving conscientiousness through a smartphone app and telecoaching intervention: insights from multiple sclerosis and healthy aging samples	60

Prevalence of infratentorial superficial siderosis in a large general population sample from the UK Biobank	57
Prevalence of hereditary transthyretin amyloidosis in CIDP patients with red flags: a multicenter genetic screening and misdiagnosis analysis	57
Primary progressive aphasia: six questions in search of an answer	56
Explaining recovery from coma with multimodal neuroimaging	56
Exploring epigenetic modifications as potential biomarkers and therapeutic targets in amyotrophic lateral sclerosis	56
Ocrelizumab in early relapsing–remitting multiple sclerosis: first interim analysis of the MUSPO Italian prospective cohort	56
A real-world study on the utility of regular rituximab treatment for neuromyelitis optica spectrum disorder	54
Historical and current issues in HIV encephalitis, and the role of neuropathology in HIV disease: a pathological perspective	53
Complications of reversible cerebral vasoconstriction syndrome in relation to age	53
Microstructural characterization of multiple sclerosis lesion phenotypes using multiparametric longitudinal analysis	53
Disrupted and reorganized connectivity of brain networks in multiple sclerosis: a systematic review and meta-analysis of resting-state functional MRI	52
International survey on the implementation of the European and American guidelines on disorders of consciousness	52
Tau levels in platelets isolated from Huntington’s disease patients serve as a biomarker of disease severity	52
Long-term efficacy and safety of ravulizumab in adults with anti-acetylcholine receptor antibody-positive generalized myasthenia gravis: results from the phase 3 CHAMPION MG open-label extension	51
Long-term outcome after decompressive hemicraniectomy for malignant middle cerebral artery infarction	51
Triple-crush mechanism in multiple sclerosis-associated trigeminal neuralgia	50
Genetic forms of tauopathies: inherited causes and implications of Alzheimer’s disease-like TAU pathology in primary and secondary tauopathies	49
Plasma p-tau217 best captures early longitudinal cognitive changes in subjective cognitive decline compared with p-tau181 and NfL	49
SARA captures disparate progression and responsiveness in spinocerebellar ataxias	48
CSF biomarkers of B-cell activation in multiple sclerosis: a clinical perspective	48
Pallidal deep brain stimulation for patients with myoclonus-dystonia without SGCE mutations	48
Keeping an eye on Parkinson’s disease: color vision and outer retinal thickness as simple and non-invasive biomarkers	48
A decision aid is not the quick fix for improving shared decision-making in advanced Parkinson’s disease: results of a mixed methods feasibility study	48
Dopaminergic responsiveness and dopaminergic challenge tests of Parkinson’s disease: a systematic review and meta-analysis	47
Perceptual response characterization in acute vestibular implant stimulation	46
Longitudinal predictors of health-related quality of life in isolated dystonia	45
Richard Caton (1842-1926)	45
A retrospective study of autoimmune cerebellar ataxia over a 20-year period in a single institution	44
Analysis of C9orf72 repeat length in progressive supranuclear palsy, corticobasal syndrome, corticobasal degeneration, and atypical parkinsonism	43
Brain 18F-FDG PET findings and sequential vestibular testing in SCA27B: a case report	43
Comprehensive effects of Parkinson’s disease multimodal complex treatment (PD-MCT): a two-center prospective trial	43
Restless legs syndrome in Parkinson’s disease: epidemiology, pathogenetic overlaps, and clinical management	43
Recent applications of quantitative electroencephalography in adult intensive care units: a comprehensive review	43
TS-HDS autoantibody: clinical characterization and utility from real-world tertiary care center experience	43
Cavernomas: to treat or not to treat?	42
Episodic symptoms caused by neurovascular conflict of vagus nerve due to hemilateral anterior inferior cerebellar artery	41
Quantitative brainstem and spinal MRI in amyotrophic lateral sclerosis: implications for predicting noninvasive ventilation needs	41
Health-related quality of life in Japanese patients with multiple sclerosis	41
Patent foramen ovale diagnosis in young stroke patients: analysis of recurrence and mortality	41
Laura Forster (1858–1917)	40
eHealth tools to assess the neurological function for research, in absence of the neurologist: a systematic review, part II (hardware)	40
Relapses during treatment with monoclonal antibodies targeting B-cells in NMOSD	39
Sutton’s law applies to functional neurology	39
Distributions and network changes of brain activity in the acute phase of anti-NMDAR encephalitis: a MEG study	39
A novel prediction score determining individual clinical outcome 3 months after juvenile stroke (PREDICT-score)	38
Retreating migraine patients in the second year with monoclonal antibodies anti-CGRP pathway: the multicenter prospective cohort RE-DO study	38
Dysregulation of the molecular clock by blood-borne factors in Alzheimer’s disease patients	38
Outcome predictors of post-COVID conditions in the European Academy of Neurology COVID-19 registry	38
Encephalitis in HIV-infected adults in the antiretroviral therapy era	38
Cost effectiveness of different treatment strategies with natalizumab for pregnant women with multiple sclerosis	38

Challenges in multinational rare disease clinical studies during COVID-19: regulatory assessment of cipaglucosidase alfa plus miglustat in adults with late-onset Pompe disease	38
The Sternbergers: Ludwig (1921–2008) and Nancy (1938–2014)	37
Characterisation of RT-QuIC negative cases from the UK National CJD Research and Surveillance programme	37
Bilateral beaded watershed infarction secondary to acute anemia from gastrointestinal bleeding	37
Estimation of ataxia severity in children with ataxia-telangiectasia using ankle-worn sensors	36
Translocator protein (TSPO)-PET as diagnostic and monitoring tool in COVID-19 related MRI-negative brainstem encephalitis: a case report	36
A multi-domain lifestyle intervention in multiple sclerosis: a longitudinal observational study	36
Feasibility, safety and efficacy of multi-dose vagus nerve stimulation in Parkinson’s disease: a double-blind, randomised sham-controlled proof-of-concept study	35
Air pollution, greenspace exposure and risk of Parkinson's disease: a prospective study of 441,462 participants	35
Regional brain atrophy subtypes in spinocerebellar ataxia type 3: links to clinical performance and treatment response	35
Anxiety and depression in Charcot-Marie-Tooth disease: data from the Italian CMT national registry	35
Correction: Pharmacogenomics of clinical response to Natalizumab in multiple sclerosis: a genome-wide multi-centric association study	34
Inflammatory neuropathy with evidence of anti-GQ1b antibodies in angioimmunoblastic T cell lymphoma (AITL): a case report	34
Aphasia as a stroke mimic in older adults: a diagnostic challenge	34
Effects of transcutaneous auricular vagus nerve stimulation on motor and gait performance in Parkinson’s disease: a meta-analysis of randomized controlled trials	34
Impulse control and correlation to dopamine agonist serum concentrations in people with Parkinson's disease	33
Segmental distal amyotrophy and cold paresis due to chronic CSF leak with ventral longitudinal epidural collection: a case report	33
Genetic variation of low-to-medium-affinity Fc-gamma receptors in Guillain-Barré syndrome	33
Regional distribution of polymorphisms associated to the disease-causing gene of spinocerebellar ataxia type 3	33
Is there a spinal tap responder in progressive supranuclear palsy? The first prospective study	32
Equity in neuromuscular research: a 20-year analysis of race, ethnicity, sex, and age representation	32
The intersection of delirium and long-term cognition in older adults: the critical role of delirium prevention	32
Risdiplam improves subjective swallowing quality in non-ambulatory adult patients with 5q-spinal muscular atrophy despite advanced motor impairment	32
Cognitive stimulation in Parkinson’s disease with mild cognitive impairment	32
Mismatch between clinically defined classification of ALS stage and the burden of cerebral pathology	32
Endolymphatic space is age-dependent	32
Efficacy and safety of monoclonal antibodies in the treatment of relapsing remitting multiple sclerosis: a systematic review	32
Left- vs right-sided migraine: a scoping review	32
Progression independent of relapse activity in relapsing multiple sclerosis: impact and relationship with secondary progression	32
Non-invasive biomarkers for diagnosis and monitoring of primary mitochondrial diseases	32
Longitudinal analysis and treatment of neuropsychiatric symptoms in post-acute sequelae of COVID-19	31
Matched-pair analysis of motor outcomes in adults with spinal muscular atrophy on nusinersen vs. risdiplam	31
Detection of patent foramen ovale in patients with ischemic stroke on prospective ECG-gated cardiac CT compared to transthoracic echocardiography	31
Analyzing the relationship between specific brain structural changes and the diffusion tensor image analysis along the perivascular space index in idiopathic normal pressure hydrocephalus	31
The vicious cycle: unraveling the interplay between α-synuclein, mitochondrial dysfunction, and neuroinflammation in Parkinson’s disease	30
Procedural and Clinical Outcome of Stroke after thrombectomy according to etiology: results from a nationwide registry	30
Present and future of the diagnostic work-up of multiple sclerosis: the imaging perspective	30
The role of language-related functional brain regions and white matter tracts in network plasticity of post-stroke aphasia	30
The role of serum neurofilament light (sNfL) as a biomarker in multiple sclerosis: insights from a systematic review	30
Architecture and anatomy of executive processes: evidence from verbal fluency and Trail Making Test in 2009 stroke patients	30
Long-term clinical outcomes in patients with CIS treated with interferon beta-1b: results from the 15-year follow up of the BENEFIT trial	30
The topography of infratentorial lesions in depression and anxiety in multiple sclerosis	30
Management of hypersensitivity in a patient with late-onset Pompe disease experiencing recurrent infusion-related reactions	29
Audiovisual analysis of the diagnostic video polysomnography in patients with isolated REM sleep behavior disorder	29
Ultra-late response (> 24 weeks) to anti-CGRP monoclonal antibodies in migraine: a multicenter, prospective, observational study	29
Correction: Long-term neurological outcome after hematopoietic stem cell transplant in juvenile Krabbe disease	29
Systematic review and evidence gap mapping of biomarkers associated with neurological manifestations in patients with COVID-19	29
Biomarkers stewardship in parkinsonism: integrating alpha-synuclein seed amplification assays and neurofilament light chain into diagnostic pathways and patient communication	29
The frequency of non-motor symptoms in SCA3 and their association with disease severity and lifestyle factors	29
The clinical phenotype of psychiatric-onset prodromal dementia with Lewy bodies: a scoping review	29
Current biomarker development in myotonic dystrophies	29
Machine learning for adaptive deep brain stimulation in Parkinson’s disease: closing the loop	29
Artificial intelligence in neurology: opportunities, challenges, and policy implications	28
Amyotrophic lateral sclerosis stratification: unveiling patterns with virome, inflammation, and metabolism molecules	28
Ozone pollution as a possible trigger for multiple sclerosis in young people: the PEDIGREE study	28
Neurological update: structural and functional imaging in epilepsy surgery	28
Quantification of saccadic fatigability and diagnostic efficacy for myasthenia gravis	28
Regional free-water diffusion is more strongly related to neuroinflammation than neurodegeneration	28
Evaluating 18F-Florzolotau tau PET for Alzheimer’s disease diagnosis with 18F-Flortaucipir as reference	28
Clinical outcomes at 6 months after MRgFUS thalamotomy in Parkinson’s disease: a large longitudinal cohort study	28
Novel biomarkers and neuroimaging techniques in Parkinson’s disease	27
Recurrence and long-term outcomes of Tolosa-Hunt syndrome	27
MRI-guided focused ultrasound: new hope for drug-resistant neurological conditions	27
Rate of change in upper and lower motor neuron burden is associated with survival in amyotrophic lateral sclerosis	27
Precision diagnosis and precision treatment for the genetic epilepsies	27
Longitudinal qualitative assessment of meaningful symptoms and relevance of WATCH-PD digital measures for people with early Parkinson’s	27
Genetic risk factors of Alzheimer’s Disease disrupt resting-state functional connectivity in cognitively intact young individuals	27
Beneficial effect of N-acetyl-DL-leucine on cognitive function, emotional well-being and QoL in a mentally healthy elderly person	27
Frida Kahlo could have had cauda equina syndrome: a case report	26
Neurogenic cough in CANVAS syndrome: objective cough monitoring reveals a distinctive clinical pattern	26
The value of magnetic resonance imaging of the optic nerve for the diagnosis of multiple sclerosis in patients with optic neuritis	26
Good vibrations: tactile cueing for freezing of gait in Parkinson’s disease	26
Frequency and predictors of poststroke epilepsy after mechanical thrombectomy for large vessel occlusion stroke: results from a multicenter cohort study	26
Exploring the impact of 40 Hz multi-luminaire light exposure in Alzheimer's dementia: insights from a convenient sampling, non-randomized case–control study	26
Specific clinical and radiological characteristics of anti-NMDA receptor autoimmune encephalitis following herpes encephalitis	26
Spontaneous intracranial hypotension due to pelvic cerebrospinal fluid leak	26
Overcoming traps and pitfalls leading to misinterpretation of normal EEG variants and variation of the background activity	26
Incidence of cerebral small vessel disease-related MR markers in the Swedish general population ‘Good Aging in Skåne’(GÅS) study	26
Subjective and objective responses to caloric stimulation help separate vestibular migraine from other vestibular disorders	26
Impacts of medication non-adherence to major modifiable stroke-related diseases on stroke prevention and mortality: a meta-analysis	26

Locus coeruleus degeneration and cerebellar gray matter changes in essential tremor	26
Efficacy and safety of adjunctive perampanel treatment in pediatric patients with epilepsy aged 4–12 years: a real-world study	26
The impact of the SARS-CoV-2-pandemic on patients with chronic inflammatory neuropathies: results from the German INHIBIT register	25
Loss of brainstem white matter predicts onset and motor neuron symptoms in C9orf72 expansion carriers: a GENFI study	25
Quantitative whole-body muscle MRI in idiopathic inflammatory myopathies including polymyositis with mitochondrial pathology: indications for a disease spectrum	25
Reassessing the adverse event profiles of levetiracetam and brivaracetam: a systematic review and meta-analysis	25
Fingolimod-associated progressive multifocal leukoencephalopathy in a multiple sclerosis patient with a good response to filgrastim	25
Comparing caloric and self-experienced dizziness symptoms: diagnostic value and implications in functional dizziness	25
Correlation between cognitive changes and neuroradiological changes over time in multiple sclerosis: a systematic review and meta-analysis	25
Distal hereditary motor neuronopathy as a new phenotype associated with variants in BAG3	25
Refractory focal epilepsy evolving into a Lennox–Gastaut syndrome-like	25
The effects of dopaminergic medication and task load on trembling and akinetic freezing of gait in Parkinson’s disease	25
Accuracy of the central vein sign in diagnosis of multiple sclerosis: a systematic review and meta-analysis	25
Could galcanezumab modulate inflammatory cytokines? A single-centre exploratory study	25
Dopamine transporter single photon emission computed tomography (DaT-SPECT) use in the diagnosis and clinical management of parkinsonism: an 8-year retrospective study	24
Effectiveness of endovascular treatment for in-hospital stroke vs. community-onset stroke: a propensity score-matched analysis	24
Correction: Opicapone for the treatment of early wearing-off in levodopa-treated Parkinson’s disease: pooled analysis of patient level data from two randomized open-label studies	24
Intake reminders are effective in enhancing adherence to direct oral anticoagulants in stroke patients: a randomised cross-over trial (MAAESTRO study)	24
Orthostatic blood pressure trajectories characterize heterogeneous disease progression in Parkinson's disease	24
Usefulness of subcutaneous immunoglobulin therapy in the management of myasthenia gravis: a retrospective cohort study	24
Effect of siponimod on lymphocyte subsets in active secondary progressive multiple sclerosis and clinical implications	24
Visual quality of life in NMOSD and MOGAD: profiles, dynamics and associations with ageing and vision	24
Correction: Metabolomic profile of cerebrospinal fluid from patients with diffuse gliomas	24
A new genetic cause of spastic ataxia: the p.Glu415Lys variant in TUBA4A	23
Evaluation of drivers of treatment switch in relapsing multiple sclerosis: a study from the Italian MS Registry	23
Hypothalamic atrophy in CANVAS/RFC1	23
Motor and non-motor outcome in tremor dominant Parkinson’s disease after MR-guided focused ultrasound thalamotomy	23
The correlation between 9-HPT and patient-reported measures of upper limb function in multiple sclerosis: a systematic review and meta-analysis	23
Systematic assessment of square-wave jerks in progressive supranuclear palsy: a video-oculographic study	23
Diagnosing primary lateral sclerosis: a clinico-pathological study	23
Late-onset cerebellar ataxia in three European patients with repeat expansions in RFC1 and FGF14: a case series	23
Measuring cognitive impairment and monitoring cognitive decline in Huntington’s disease: a comparison of assessment instruments	23
Brain positron emission tomography (PET) and cognitive abnormalities one year after COVID-19	23
Case report: anti-argonaute antibodies in Epstein-Barr virus encephalitis	23
Effectiveness and safety of pharmacological prophylaxis for chronic migraine: a systematic review and network meta-analysis	23
The role of age in choosing high-efficacy treatment for multiple sclerosis: an Austrian MS Database study	23
Occurrence of area postrema syndrome during follow-up: phenotype and influence over NMOSD activity in LATAM in real-world settings	23
Increased functional network connectivity following cognitive rehabilitation in progressive multiple sclerosis with moderate to severe disabilty: findings from the CogEx study	22
Natural history of facioscapulohumeral muscular dystrophy evaluated by multiparametric quantitative MRI: a prospective cohort study	22
Fluctuations in serum aquaporin-4 antibody titers: the clinical significance in neuromyelitis optica spectrum disorder	22
Diagnostic accuracy and confounders of vagus nerve ultrasound in amyotrophic lateral sclerosis—a single-center case series and pooled individual patient data meta-analysis	22
Widespread and progressive brain atrophy is a common feature in patients with mitochondrial disease	22
Effectiveness of telemedicine-based rehabilitation after stroke: a systematic review	22
Epileptogenicity of white matter lesions in cerebral small vessel disease: a systematic review and meta-analysis	22
Spinocerebellar ataxia 27B: a frequent and slowly progressive autosomal-dominant cerebellar ataxia—experience from an Italian cohort	22
Early use of high-efficacy therapies in multiple sclerosis in the United States: benefits, barriers, and strategies for encouraging adoption	22
Correction: Ozone pollution as a possible trigger for multiple sclerosis in young people: the PEDIGREE study	22
External sensory cueing on gait in Parkinson’s disease: a systematic review and network meta-analysis	22
Morbidity and medication use preceding a diagnosis of late-onset Alzheimer’s disease: a Danish nationwide study	22
Different approaches to test orientation of self in space: comparison of a 2D pen-and-paper test and a 3D real-world pointing task	22
Association of rare variants in genes of immune regulation with pediatric autoimmune CNS diseases	22
Plasma NfL and GFAP in the preclinical stages of neurodegenerative diseases: insights from the UK Biobank	21
Integrating standard and native spaces for radiomics and brain network analysis in Alzheimer’s disease diagnosis and prognosis	21
Effects of motor–cognitive training on dual-task performance in people with Parkinson’s disease: a systematic review and meta-analysis	21
(William) Ritchie Russell (1903–1980)	21
Upper motor neuron-predominant motor neuron disease: a novel immunotherapy-responsive association of GAD65 autoimmunity	21
Parkinson’s disease with hyposmia and dysautonomia: does it represent a distinct subtype?	21
Unprescribed cannabinoids and multiple sclerosis: a multicenter, cross-sectional, epidemiological study in Lombardy, Italy	21
Conjugate torsional pendular nystagmus and palatal tremor after unilateral internuclear ophthalmoplegia	21
Leg stereotypy syndrome: phenomenological and quantitative analysis	21
Retinal thickness as a biomarker of cognitive impairment in manifest Huntington’s disease	21
Muscle MRI as a biomarker of disease activity and progression in myotonic dystrophy type 1: a longitudinal study	21
CSF phospho-tau levels at Parkinson’s disease onset predict the risk for development of motor complications	21
Treatment of functional neurological disorder: an umbrella review of systematic reviews and meta-analyses	21
Louis Jacobsohn-Lask (1863–1940)	21
The impact of an MSU service on acute stroke care in a middle-sized city: a simulation-based analysis	21
A rare case of a wall-eyed bilateral internuclear ophthalmoplegia (WEBINO) syndrome in a patient with cutaneous lupus erythematosus after COVID-19 infection	20
A phenomenological approach to spastic movement disorders: an international expert panel consensus	20
Marked increase in severe neurological disorders after nitrous oxide abuse: a retrospective study in the Greater Paris area	20
Corneal edema: an underrecognized safety risk of amantadine	20
Elevated serum concentrations of GFAP in hereditary transthyretin amyloidosis since pre-symptomatic stages	20
A disproportionality analysis of surgical site infections across multiple sclerosis disease modifying therapies	20
Optic neuritis and MOGAD	20
Chronic vertigo and central oculomotor dysfunction with evidence of anti-ITPR1 antibodies	20
Eye movement abnormalities in normal pressure hydrocephalus: a video-oculographic study	20
Radiologically isolated syndromes: to treat or not to treat?	20
Characteristics of HHV-7 meningitis: a systematic review	20
Neurosarcoidosis	20
Real-life evaluation of the 2017 McDonald criteria for relapsing–remitting multiple sclerosis after a clinically isolated syndrome confirms a gain in time-to-diagnosis	20
COVID-19 infection after SARS-CoV-2 mRNA vaccination in Multiple Sclerosis, AQP4-antibody NMOSD and MOGAD patients during the Omicron subvariant BA.1/2 wave in Singapore	20
Correction to: Outcomes of mechanical thrombectomy in patients with acute ischemic stroke and thrombocytopenia: systematic review and meta-analysis	20
Explaining cognitive function in multiple sclerosis through networks of grey and white matter features: a joint independent component analysis	20
Olfactory dysfunction is common in classical infratentorial superficial siderosis of the central nervous system	20
Diagnostic utility of neurofilament markers for MND is limited in restricted disease phenotype and for differentiation from compressive myeloradiculopathies	20
Chimeric antigen receptor T-cell therapy for autoimmune diseases of the central nervous system: a systematic literature review	20
Results of a phase II open-label, multiple-dose study of vamorolone (VBP15-006) in 7- to < 18-year-old boys with duchenne muscular dystrophy	20
Serum neurofilament light chain associates with symptom burden in Lyme neuroborreliosis patients: a longitudinal cohort study from Norway	20
Stroke in adults with primary intracranial tumours	20
Risk and sex-specific trends of dementia and stroke in Italy Compared to European and high-income countries and the world: global implications	20
Endovascular thrombectomy with or without intravenous alteplase in acute stroke: a systematic review and meta-analysis of randomized clinical trials	20
Satralizumab as a treatment for pediatric-onset neuromyelitis optica spectrum disorder with cluster attack: a case report	20
Differentiating anti-IgLON5 disease and Lewy body dementia: a systematic review	19
Prevalence, risk factors, and clinical outcomes of remote intracerebral hemorrhage after intravenous thrombolysis in acute ischemic stroke: a systematic review and meta-analysis	19
Muscle quantitative MRI as a novel biomarker in hereditary transthyretin amyloidosis with polyneuropathy: a cross-sectional study	19
A nationwide epidemiological study of myasthenia gravis in Turkey	19